Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wijermans

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Leukemia Research|January 1, 1990
Differentiation induction of HL60 cells in a long-term bone marrow culture of acute myeloid leukemiaG J Ossenkoppele, I Denkers, P Wijermans, et al.
Annals of Hematology|April 15, 2015
Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette studyM W M van der Poel, W J Mulder, G J Ossenkoppele, et al.
The Netherlands Journal of Medicine|May 22, 2014
Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologistsM W M van der Poel, W J Mulder, G J Ossenkoppele, et al.
British Journal of Haematology|August 24, 2005
Splenectomy for the treatment of thrombotic thrombocytopenic purpuraM C Kappers-Klunne, P Wijermans, R Fijnheer, et al.
Journal of Clinical Immunology|October 1, 1982
Changes in human T lymphocytes after thymectomy and during senescenceR J Van de Griend, M Carreno, R Van Doorn, et al.
Clinical and Laboratory Haematology|January 26, 2000
Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumerationJ W Gratama, E Braakman, J Kraan, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Blood|November 5, 1997
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative GroupB Löwenberg, S Suciu, E Archimbaud, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Leukemia Research|January 1, 1990
Differentiation induction of HL60 cells in a long-term bone marrow culture of acute myeloid leukemiaG J Ossenkoppele, I Denkers, P Wijermans, et al.
Annals of Hematology|April 15, 2015
Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette studyM W M van der Poel, W J Mulder, G J Ossenkoppele, et al.
The Netherlands Journal of Medicine|May 22, 2014
Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologistsM W M van der Poel, W J Mulder, G J Ossenkoppele, et al.
British Journal of Haematology|August 24, 2005
Splenectomy for the treatment of thrombotic thrombocytopenic purpuraM C Kappers-Klunne, P Wijermans, R Fijnheer, et al.
Journal of Clinical Immunology|October 1, 1982
Changes in human T lymphocytes after thymectomy and during senescenceR J Van de Griend, M Carreno, R Van Doorn, et al.
Clinical and Laboratory Haematology|January 26, 2000
Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumerationJ W Gratama, E Braakman, J Kraan, et al.
Leukemia|March 1, 1997
A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)R Willemze, S Suciu, E Archimbaud, et al.
Blood|November 5, 1997
Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative GroupB Löwenberg, S Suciu, E Archimbaud, et al.
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Pageof 3